4[1]Ofosu FA,Barrowcliffc TW.Mechanisms of action of low molecular weight heparins and heparinoids in antithromlxtic therapy[J].Bailliere Clinical Heamatology,1990,3:505.
5[2]Fared J,Walenga JM,Hoppensteadt D,et al.Comparative study on the in vitro and in vivo studies of seven low-molecular weight heparins[J].Haemostasis,1998,18:3.
7[4]Lane DA,Pejler G,Flynn AM.Neutralization of heparin-related saccharides by histidine-rich glycoprotcin and platelet factor[J].J Biol Chem,1986,261:3980.
8[5]Bone UB,Caranobe C,Cadry DF.Pharmacokinetic studies of standard unfractionated heparin and low molecular weight hearins in the rabbit serum[J].Thromb Haemost,1988,14:18.
9[6]Palm M,Mattsson CH.Pharmacokinetics of heparin and low molecular weigt heparin fragment in rabbit with impaired renal or metabolic clearance[J].Thromb Haemost,1987,58:923.
10[7]Melissari E,Parker CJ,Wilson NV,et al.Use of LMWH in pregnancy[J].Thromb Haemost,1992,68:652.
